Lydia C T Buer

3PUBLICATIONS
6CO-AUTHORS
Immunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 28, 2024
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study.

Thea H Wiken, Marte L Høivik, Karoline Anisdahl

|Feb 17, 2023
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring.

Thea H Wiken, Marte L Høivik, Lydia Buer

|Jan 17, 2019
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort.

Lydia C T Buer, Bjørn A Moum, Milada Cvancarova

Pageof 1

Frequent Collaborators

2 joint publications

Thea H Wiken

2 joint publications

Karoline Anisdahl

2 joint publications

Asle W Medhus

1 joint publications

Marte L Høivik